DDR Drug Development & Regulation is now part of the Veristat global regulatory team. Offering bold thinking and scientific-minded regulatory expertise to ensure the successful navigation of regulatory requirements for drugs, biologics, and medical devices in Europe, North America, and other world regions is our core focus. Xavier Luria, M.D., is now the Vice President of Regulatory Affairs, Europe at Veristat. He continues to lead the European regulatory team, which combined the Veristat and all of the DDR regulatory team members.
We always have and will continue to deliver regulatory strategies and insights for success. Meet Veristat.
